Physician profile
Jarrett Hamilton
NPI 1033206131
$4,999.27
in general payments reported to CMS, 2019-2025
17 companies · $2,233 in 2025
The $2,233 reported for 2025 was more than what 85% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $630 · 2020: $59.53 · 2021: $162 · 2022: $40.72 · 2023: $115 · 2024: $1,760 · 2025: $2,233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,064 · Food and Beverage: $1,031 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,063.75 |
| Food and Beverage | $1,031.13 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $3,697.72 | 2019-2025 | |
| Smith+Nephew, INC. | $492.82 | 2019-2024 | Collagenase Santyl, Integra, Stravix Pl |
| Stryker Corporation | $205.78 | 2024-2025 | Easyfuse, Augment Injectable, Pangea |
| Bioventus LLC | $119.86 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Integra Lifesciences Corporation | $89.30 | 2019 | |
| Invictus Surgical Incorporated | $63.75 | 2024-2025 | |
| Organogenesis INC. | $63.65 | 2021-2025 | Apligraf |
| Merck Sharp & Dohme LLC | $38.92 | 2024-2025 | Vaxneuvance, Capvaxive, Enflonsia |
| Tactile Systems Technology INC | $34.34 | 2022-2023 | Entre Plus, Flexitouch Plus |
| Globus Medical, INC. | $30.78 | 2025 | Senza |
| Progenics Pharmaceuticals, INC. | $29.57 | 2024 | |
| Misonix INC | $29.01 | 2020 | |
| Neurocrine Biosciences, INC. | $27.02 | 2025 | |
| Tolmar, INC. | $26.40 | 2024 | |
| Pacira Therapeutics, INC. | $18.63 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $18.25 | 2025 | |
| Grifols USA, LLC | $13.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jarrett Hamilton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.